Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Doping

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43892   clinical trials with a EudraCT protocol, of which   7299   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    12 result(s) found for: Doping. Displaying page 1 of 1.
    EudraCT Number: 2016-002819-18 Sponsor Protocol Number: WADA2016Sal Start Date*: 2016-12-14
    Sponsor Name:Bispebjerg University Hospital
    Full Title: Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis
    Medical condition: Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2014-005186-73 Sponsor Protocol Number: WADA2014Pred Start Date*: 2015-03-18
    Sponsor Name:Bispebjerg University Hospital
    Full Title: Impact of intense exercise on pharmacokinetics of glucocorticoides in relation to doping analysis
    Medical condition: Impact of intense exercise on pharmacokinetics of glucocorticoids in relation to doping analysis
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-005056-96 Sponsor Protocol Number: TRAWADA2015 Start Date*: 2016-05-31
    Sponsor Name:Daniel Sanabria Lucena
    Full Title: Use of tramadol in healthy volunteers. Effects on physical performance and sustained attention in cycling.
    Medical condition: Sport doping
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004873 10076471 Drug doping LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2014-001655-23 Sponsor Protocol Number: 01-testgel-14 Start Date*: 2015-05-27
    Sponsor Name:Rodrigo Aguilera
    Full Title: Establishment of an Athlete's Internal Metabolic Reference Using an Isotopic Signature or Isotopic Fingerprint of ?13C Values
    Medical condition: SPORT DOPING
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004848 10059568 Urine dihydrotestosterone LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002655-16 Sponsor Protocol Number: 2007-002655-16 Start Date*: 2008-03-31
    Sponsor Name:Karolinska Institutet
    Full Title: Androgen metabolism and doping tests
    Medical condition: Healthy volunteers will be studied regarding androgen metabolism and doping tests.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2018-002529-48 Sponsor Protocol Number: WADA2018vil Start Date*: 2018-09-12
    Sponsor Name:Center for Aktiv Sundhed, Rigshospitalet
    Full Title: Urine concentrations of vilanterol after inhaled administration of vilanterol/fluticasone furoate: Defining a urine threshold and decision limit for vilanterol in doping control analysis
    Medical condition: Pharmacokinetics of vilanterol in relation to doping analysis
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004848 10053349 Pharmacokinetic study LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-000388-10 Sponsor Protocol Number: WADA_17C09 Start Date*: 2019-06-11
    Sponsor Name:Daniel Sanabria
    Full Title: Clinical trial on the effects of the tramadol and paracetamol on physical, cognitive and brain performance during cycling
    Medical condition: Sports doping
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-005135-24 Sponsor Protocol Number: ECDOPDEP2013 Start Date*: 2014-03-21
    Sponsor Name:Cristina Fernandez Pérez
    Full Title: Clinical Trial crossed athletic population according UGT2B17 polymorphism. Impact on the steroid profile
    Medical condition: Sports doping
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004848 10043364 Testosterone LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2014-000563-41 Sponsor Protocol Number: IMIMFTCL/GH/4 Start Date*: 2014-08-08
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)
    Full Title: Recombinant hGH Biomarkers Discovery
    Medical condition: Healthy volunteers. There is not intended indication.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-002170-52 Sponsor Protocol Number: 66242 Start Date*: 2019-03-04
    Sponsor Name:VU University Medical Center (VUmc)
    Full Title: TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction
    Medical condition: Heart failure with preserved ejection fraction (HFpEF)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2006-001889-16 Sponsor Protocol Number: CLB-2006 Start Date*: 2006-03-01
    Sponsor Name:AZIENDA OSPEDALIERA SENESE
    Full Title: Use of clembuterol in patients affected by valvular hearth disease and dilated cardiomyopathy
    Medical condition: No healthy subjects (patients affected by valvular hearth disease and dilated cardiomyopathy)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024119 Left ventricular failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000670-20 Sponsor Protocol Number: BUB2008JE Start Date*: 2009-05-11
    Sponsor Name:Respitatory and Allergy Research Unit
    Full Title: Blood- and urinary concentrations of salbutamol in asthmatics and elite athletes with asthma; comparison between inhalation vs. oral administration.
    Medical condition: The purpose of this study is to assess the plasma and urine concentrations of salbutamol and evaluate the difference between inhaled og oral administration in three groups; healthy men, asthmatics ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003560 Asthma NOS LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 29 16:18:49 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA